Sensei Biotherapeutics is reducing its workforce by 65% as it evaluates strategic options in a weak fundraising environment.

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

Philadelphia is joining the San Francisco Bay area, Boston, and San Diego as a host of a Lilly Gateway Labs biotech incubator ...

As the biopharma world predominantly zeroes in on late-stage assets, Eli Lilly is prioritizing early science with the opening ...

ImmunityBio shows strong commercial momentum with ANKTIVA, reporting significant revenue growth and improved net loss in Q3.

Building an ethical business from day one can be a strategic advantage that attracts partners, talent and investors who care ...

Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with ...

Despite a recent capital raise, Shelton-based antiviral drug developer NanoViricides Inc. disclosed it does not have enough ...

NYU Langone Health is relocating its early-stage biotech incubator from Manhattan to a 46,000-square-foot facility in Long ...

A science-first biotech fund just sized up its stake in an ALS-focused company heading into a pivotal year for the firm.

Three regional institutions signed an agreement creating the MV Biotech Collective in Utica, establishing a partnership to ...